Access count of this item: 204

Files in This Item:
File Description SizeFormat 
41_227.pdf4.65 MBAdobe PDFView/Open
Title: 膀胱癌肺転移巣に対してMethotrexate,Epirubicin,Cisplatinの多剤併用化学療法が著効を示した1例
Other Titles: Complete response of lung metastasis from bladder cancer by combination chemotherapy with methotrexate, epirubicin and cisplatin: a case report
Authors: 大内, 秀紀  KAKEN_name
野口, 純男  KAKEN_name
増田, 光伸  KAKEN_name
執印, 太郎  KAKEN_name
窪田, 吉信  KAKEN_name
穂坂, 正彦  KAKEN_name
Author's alias: Oouchi, Hideki
Noguchi, Sumio
Masuda, Mitsunobu
Shuin, Taro
Kubota, Yoshinobu
Hosaka, Masahiko
Keywords: Lung metastasis
Bladder cancer
Combination chemotherapy
Issue Date: Mar-1995
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 41
Issue: 3
Start page: 227
End page: 230
Abstract: We report a case of lung metastasis from bladder cancer effectively responding to a combination chemotherapy using methotrexate, epirubicin and cisplatin (MEC therapy). A 78-year-old man with high grade bladder cancer underwent total cystectomy on June 5, 1991. He was pointed out to have an abnormal shadow on the plain chest X-ray on August 14, 1992. Computed tomography demonstrated multiple lung metastasis. MEC combination chemotherapy was applied for this case. After 3 courses of MEC therapy, computed tomography showed marked regression of tumor. He has been alive for 12 months with no evidence of disease after chemotherapy. Toxicity of MEC therapy were moderate myelosuppression and mild anorexia and alopecia. These toxicity was adequately tolerable by the 78-year-old patient. This case suggests that MEC therapy is effective against advanced bladder cancer.
PubMed ID: 7741078
Appears in Collections:Vol.41 No.3

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.